These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17375091)

  • 1. Out of Africa: what can we learn from HIV-2 about protective immunity to HIV-1?
    Rowland-Jones SL; Whittle HC
    Nat Immunol; 2007 Apr; 8(4):329-31. PubMed ID: 17375091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An underestimated lentivirus model: what can HIV-2 research contribute to the development of an effective HIV-1 vaccine?
    Hodges-Mameletzis I; De Bree GJ; Rowland-Jones SL
    Expert Rev Anti Infect Ther; 2011 Feb; 9(2):195-206. PubMed ID: 21342067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the gut the major source of virus in early simian immunodeficiency virus infection?
    Lay MD; Petravic J; Gordon SN; Engram J; Silvestri G; Davenport MP
    J Virol; 2009 Aug; 83(15):7517-23. PubMed ID: 19458001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonpathogenic simian immunodeficiency virus infection of sooty mangabeys is not associated with high levels of autologous neutralizing antibodies.
    Li B; Stefano-Cole K; Kuhrt DM; Gordon SN; Else JG; Mulenga J; Allen S; Sodora DL; Silvestri G; Derdeyn CA
    J Virol; 2010 Jun; 84(12):6248-53. PubMed ID: 20375163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular immune response to SIVmac and HIV-2 in macaques: model for the human HIV-1 infection.
    Voss G; Hunsmann G
    J Acquir Immune Defic Syndr (1988); 1993 Sep; 6(9):969-76. PubMed ID: 8340900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-function studies of the HIV-1 coreceptors.
    Berson JF; Doms RW
    Semin Immunol; 1998 Jun; 10(3):237-48. PubMed ID: 9653050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural SIV hosts: showing AIDS the door.
    Chahroudi A; Bosinger SE; Vanderford TH; Paiardini M; Silvestri G
    Science; 2012 Mar; 335(6073):1188-93. PubMed ID: 22403383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD127 and CD25 expression defines CD4+ T cell subsets that are differentially depleted during HIV infection.
    Dunham RM; Cervasi B; Brenchley JM; Albrecht H; Weintrob A; Sumpter B; Engram J; Gordon S; Klatt NR; Frank I; Sodora DL; Douek DC; Paiardini M; Silvestri G
    J Immunol; 2008 Apr; 180(8):5582-92. PubMed ID: 18390743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversion of immune escape HIV variants upon transmission: insights into effective viral immunity.
    Kent SJ; Fernandez CS; Dale CJ; Davenport MP
    Trends Microbiol; 2005 Jun; 13(6):243-6. PubMed ID: 15936652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-directed enzyme-linked immunosorbent assay with a synthetic simian immunodeficiency virus SIVmac peptide identifying antibodies against the HIV-2 transmembrane glycoprotein.
    Norrby E; Chiodi F; Whalley A; Parks E; Nauclér A; Costa CM; Torstensson R; Biberfeld G
    AIDS; 1989 Jan; 3(1):17-20. PubMed ID: 2469436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human and simian immunodeficiency virus-infected chimpanzees do not have increased intracellular levels of beta-chemokines in contrast to infected humans.
    Ondoa P; Vereecken C; Fransen K; Colebunders R; van der Groen G; Heeney JL; Kestens L
    J Med Virol; 2003 Mar; 69(3):297-305. PubMed ID: 12526038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Searching for the epidemic's origins.
    Cohen J
    Science; 2000 Jun; 288(5474):2164-5. PubMed ID: 10896603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into evaluating effective T-cell responses to HIV.
    Allen TM; Watkins DI
    AIDS; 2001; 15 Suppl 5():S117-26. PubMed ID: 11816159
    [No Abstract]   [Full Text] [Related]  

  • 14. Functional Perturbation of Mucosal Group 3 Innate Lymphoid and Natural Killer Cells in Simian-Human Immunodeficiency Virus/Simian Immunodeficiency Virus-Infected Infant Rhesus Macaques.
    Hueber B; Curtis AD; Kroll K; Varner V; Jones R; Pathak S; Lifton M; Van Rompay KKA; De Paris K; Reeves RK
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31801861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological reactivities of Ghanaian sera with HIV-1, HIV-2, and simian immunodeficiency virus SIVagm.
    Kawamura M; Ishikawa K; Mingle JA; Osei-Kwasi M; Afoakwa SN; Nettey VB; Chosa T; Hayami M
    AIDS; 1989 Sep; 3(9):609-11. PubMed ID: 2551342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of antibody on viral kinetics in simian/human immunodeficiency virus infection: implications for vaccination.
    Zhang L; Ribeiro RM; Mascola JR; Lewis MG; Stiegler G; Katinger H; Perelson AS; Davenport MP
    J Virol; 2004 May; 78(10):5520-2. PubMed ID: 15113932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4-independent infection of HIV and SIV: implications for envelope conformation and cell tropism in vivo.
    Bhattacharya J; Peters PJ; Clapham PR
    AIDS; 2003; 17 Suppl 4():S35-43. PubMed ID: 15080178
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of SHIVs with circulating, transmitted HIV-1 variants.
    Sharma A; Boyd DF; Overbaugh J
    J Med Primatol; 2015 Oct; 44(5):296-300. PubMed ID: 26101933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+ T-cell subsets: what really counts in preventing HIV disease?
    Mason RD; De Rose R; Kent SJ
    Expert Rev Vaccines; 2008 Mar; 7(2):155-8. PubMed ID: 18324885
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa: significantly lower plasma virus set point in HIV-2 infection than in HIV-1 infection.
    Andersson S; Norrgren H; da Silva Z; Biague A; Bamba S; Kwok S; Christopherson C; Biberfeld G; Albert J
    Arch Intern Med; 2000 Nov; 160(21):3286-93. PubMed ID: 11088091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.